Document is current
Any future updates will be listed below
-
Authors
Rajagopal, Padma Sheila https://orcid.org/0000-0002-0489-0819
Reid, Sonya
Fan, Run
Venton, Lindsay https://orcid.org/0000-0002-5418-4437
Weidner, Anne https://orcid.org/0000-0002-8007-8734
Roberson, Mya L.
Vadaparampil, Susan
Wang, Xuefeng
Yoder, Sean
Rosa, Marilin
Sanders, Melinda
Gonzalez-Ericsson, Paula https://orcid.org/0000-0002-6292-6963
Hirbo, Jibril
Whisenant, Jennifer G.
Pietenpol, Jennifer
Ye, Fei
Pal, Tuya
Lehmann, Brian D.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (3U01CA254832-03S1, CA098131, CA068485)
Susan G. Komen
American Association for Cancer Research (22-20-73-ROBE)
- License Information
-
More Information
Article History
Received: 20 April 2024
Accepted: 4 February 2025
First Online: 11 March 2025
Competing interests
: JP and BDL are inventors (US Patent No. 11,788,147) of intellectual property (TNBCtype) licensed by Oncocyte Corp. No other authors disclosed relevant conflicts of interest. Padma Sheila Rajagopal: None. Sonya Reid: None. Run Fan: None. Lindsay Venton: None. Anne Weidner: None. Mya Roberson: None. Susan Vadaparampil: None. Xuefeng Wang: None. Sean Yoder: None. Marilin Rosa: None. Melinda Sanders: None. Paula Gonzalez-Ericsson: None. Jibril Hirbo: None. Jennifer Whisenant: None. Jennifer Pietenpol: Drs. Pietenpol and Lehmann are inventors (US Patent No. 11,788,147) of intellectual property (TNBCtype) licensed by Oncocyte Corp. Fei Ye: None. Tuya Pal: None. Brian Lehmann: Drs. Pietenpol and Lehmann are inventors (US Patent No. 11,788,147) of intellectual property (TNBCtype) licensed by Oncocyte Corp.
